The compatibility of INTRASITE Gel and ACTICOAT : An In-Vivo and In-Vitro assessment. *smith&nephew
|
|
- Calvin Dickerson
- 5 years ago
- Views:
Transcription
1 The compatibility of INTRASITE Gel and ACTICOAT : An In-Vivo and In-Vitro assessment *smith&nephew
2 An In-Vivo and In-Vitro assessment of the compatibility of ACTICOAT and ACTICOAT 7 with INTRASITE Gel dressings in the management of chronic wounds Introduction ACTICOAT and ACTICOAT 7 (with SILCRYST TM Nanocrystals) are effective antimicrobial barrier dressings which are indicated for use on partial and full thickness wounds such as pressure ulcers, venous ulcers, diabetic ulcers, burns, donor and recipient graft sites. In-Vitro data has demonstrated that the nanocrystalline coating of silver rapidly kills a broad spectrum of bacteria in as little as 30 minutes. ACTICOAT must be kept moist to be effective. When exposed to moisture it can maintain bactericidal activity for at least 3 days. With ACTICOAT 7 bactericidal activity can be maintained for up to 7 days. This bactericidal activity will help to prevent and reduce infection of wounds. Keeping ACTICOAT and ACTICOAT 7 dressings moist, may require rewetting of the dressing with sterile water. However, some clinicians are using INTRASITE Gel/Conformable together with ACTICOAT and ACTICOAT 7 in order to keep the dressings, and the wound moist for longer periods of time. Case studies have been undertaken to show the effectiveness of this combination in the treatment of chronic wounds. To support these two invitro tests have been carried out to investigate the compatibility of the two dressings.
3 Dr. Juan Carlos López Gutierrez Hospital Infantil La Paz- Cirugía Pediátrica Pº de la Castellana, Madrid, Spain The use of ACTICOAT on a severe trauma wound in a paediatric patient This case study demonstrates the use of ACTICOAT in combination with reconstructive surgery and tissue replacement in a paediatric patient with severe trauma. The patient was a 3 and a half year old boy with a trauma wound as a result of a traffic accident. Originally, the patient suffered an open femur fracture to the left leg with injury to the femoral artery, femoral vein and sciatic nerve. Figure 1 After reconstruction of the sciatic nerve and blood vessels, the patient presented with a blood clot of the femoral artery and tissue destruction of the muscles of the thigh, lower leg and the front of the foot (Figures 1, 2 & 3). Treatment ACTICOAT was applied along with INTRASITE Conformable for 8 days to avoid desiccation and infection of the bone (Figures 4 & 5). IntegraTM was applied (Figure 6) and covered with ACTICOAT to prevent infection. After 5 months of treatment (Figures 7 & 8), despite sciatic paralysis, the patient could walk without assistance. Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 TM Johnson & Johnson
4 Marcus Guergen, Senior consultant surgeon Head of Outpatient Wound Clinic, Dept. of Surgery, Sørlandet Sykehus HF, Flekkefjord, Norway The effect of ACTICOAT 7 and INTRASITE Gel on a mixed aetiology leg ulcer Fig1 - The wound at commencement of treatment. Background The patient was a 67 year-old female with a small ulcer on the top of her right foot, which had been present for approximately 6 months. On examination on 19th December 2001, the ulcer measured 2.0cm x 1.5cm x 0.4cm, with slough present in the ulcer bed. The skin surrounding the ulcer, measuring approximately 16cm x 10cm was reddened. Considerable pain was experienced by the patient. The cause of the ulcer was classified as a combination of arterial and venous disease, complicated by an allergic reaction around the ulcer. Treatment The ulcer was first debrided under local anaesthetic. Following debridement the ulcer site was treated with INTRASITE Gel and ACTICOAT 7, whilst the allergic reaction was treated with hydrocortisone 1% ointment. The dressing was removed, and the ulcer assessed once a week. The Outcome On examination of the ulcer on 19th January 2002, granulation tissue was present in the wound bed, and the ulcer had reduced in size to 1.0cm x 0.8cm x 0.1cm (see fig. 2). The reddening of the skin surrounding the ulcer had improved considerably, and the patient experienced less pain. Figure 2 - The wound at 17th January 2002 A further examination on the 25th February 2002 showed that the ulcer had further reduced in size, and now measured 0.3cm x 0.3cm with granulation tissue reaching the edges of the ulcer (see fig. 3). The reddened skin surrounding the ulcer had shown further improvement, and the patient no longer was experiencing any pain. At this point, the treatment with ACTICOAT 7 was stopped, and local therapy continued using hydrocolloid dressings. At a final examination on 16th April 2002 the ulcer had healed completely with just a scar and signs of hyper-pigmentation present. An ulcer which earlier had not shown any signs of progression, despite various treatment therapies, progressed well, and without complications when ACTICOAT 7 (in conjunction with INTRASTE Gel) was used. This treatment regime provided a high degree of patient comfort. Figure 3 - The wound at 25th February 2002 Fig 4 - The wound at 16th April 2002
5 Marcus Guergen, Senior consultant surgeon Head of Outpatient Wound Clinic, Dept. of Surgery, Sørlandet Sykehus HF, Flekkefjord, Norway The use of ACTICOAT 7 and INTRASITE Gel on a patient s trauma wound with venous insufficiency Background This case study is about an 81 year old lady who fell in her home in March 2002 and suffered a large wound in the area medial to the kneecap. She had previously been a patient at the Outpatient Wound Clinic due to a large ulcer on her right leg. This had been treated with, among other things, skin grafting and treatment was completed on 5 March The patient was known to have venous insufficiency. Wound evaluation The patient came to the Outpatient Wound Clinic on the 15 April 2002 (Figure 1). Examination showed a large necrotic wound medial to the patella with the dimensions 8.0 x 3.5 x 1.5 cm. The ulcer did not probe to bone. There were evident signs of infection. There was no doubt that the wound was in the inflammation stage. The patient was admitted to the hospital. Figure 1 - The wound before commencement of treatment 15 April 2002 Treatment Debridement was performed surgically, and a 10-day course of systemic antibiotic therapy was started. This was done to prevent the infection spreading into the joint. ACTICOAT 7 moistened with sterile water was used in combination with INTRASITE Gel as local therapy. The wound was assessed every other day while the patient was in the hospital, just by lifting up the ACTICOAT 7 dressing. This allowed us full control of the wound. The patient was sent home after one week at the hospital on 22 April 2002 (Figure 2). The wound was now granulating. The treatment continued at the Outpatient Wound Clinic where a new ACTICOAT 7 dressing was applied once a week. The patient reported the dressing as being very comfortable and allowed her to continue her daily activities as normal. Figure 2 - The wound at 22 April 2002 Examination on 27 May 2002 (Figure 3) showed an ulcer reduced from 8.0 x 3.5 x 1.5 cm to 4.0 x 2.2 cm. Granulation tissue was present on the wound bed and there were no signs of infection. The ulcer marginsshowed signs of re-epithelialisation. Skin grafting proved to be unnecessary. Use of ACTICOAT 7 was stopped, and the ulcer was treated locally with ALLEVYN. Conclusion This case study shows the successful use of ACTICOAT 7 on a patient with venous insufficiency and an infected traumatic wound. Figure 3 - The wound at 27th May.
6 In-Vitro assessments of the compatibilty of ACTICOAT and INTRASITE Gel dressings Introduction To support the use of ACTICOAT in conjunction with INTRASITE Gel, two in-vitro tests have been undertaken to investigate the compatibility of the two dressings: Test 1: ACTICOAT bioactivity when used with INTRASITE Gel - to confirm INTRASITE Gel does not affect the activity of ACTICOAT Test 2: The rheological effect of INTRASITE Gel when used with ACTICOAT - to confirm ACTICOAT does not affect the rheology of INTRASITE Gel Test 1: ACTICOAT bioactivity when used with INTRASITE Gel Method Two in-vitro antimicrobial activity tests were used to determine the ability of the dressing to kill a variety of important clinical pathogens. Bacterial Reduction Test (Log) This test is performed to determine the ability of the dressings to kill a wide variety of important clinical pathogens. Inocula of bacteria, suspended in tryptic soy broth, were applied directly to the surface of the dressings. After 30 minutes and 2 hours the bacterial reduction of viable organisms remaining on each of the dressing was compared. The microorganisms used in this experiment were: S. aureus and P. aeruginosa, (two antibiotic resistant strains of these organisms). Corrected zone of inhibition - Specimens of each of the dressings were placed onto a lawn of bacteria (P. aeruginosa) and the zone of no growth surrounding the dressing was determined over a 24 hour incubation period then the specimen was transferred to a fresh lawn of bacteria. This is repeated every 24 hours for a 7 day period and the zone of no growth determined after each incubation. 2.54cm x 2.54 cm pieces of ACTICOAT dressing were coated with 0.7 g of INTRASITE Gel. For comparative purposes, the coated ACTICOAT dressing without wound gel was also tested. ACTICOAT dressing pieces were inoculated with 0.2 ml of a bacterial suspension. An untreated ACTICOAT dressing served as the control. The rest of the test was conducted as per the procedure except that S. aureus samples were eluted in STS with increased NaCl to facilitate elution of the organisms. Results Results from the CZOI tests are shown in Table 1.The results from the Log Reduction Tests are shown in Table 2 Table 1: CZOI of ACTICOAT dressing coated with INTRASITE Gel Sample CZOI (mm) vs P. aeruginosa CZOI (mm) vs S. aureus Test ACTICOAT control Test ACTICOAT control INTRASITE Gel treated dressing Table 2: Log reduction in bacterial load by ACTICOAT dressing coated with INTRASITE Gel Hydrogel Log reduction in Ps.aeruginosa Log reduction in S. aureus 30min incubation 2 hr incubation 30min incubation 2 hr incubation Untreated ACTICOAT 5.6 NT INTRASITE Gel treated dressing NT = Not tested 5.3 NT
7 In-Vitro assessments of the compatibilty of ACTICOAT and INTRASITE Gel dressings cont... ACTICOAT with INTRASITE Gel gave zone sizes similar to the ACTICOAT dressing used alone. Reduction in bacterial count for treated and untreated ACTICOAT dressings are tabulated in Table 2. When P. aeruginosa was used as the inoculum, both plain and treated ACTICOAT dressings reduced the microbial load to a non-detectable levels within 30 minutes. For S. aureus, the gel treated ACTICOAT did display reduced kill rates relative to the regular ACTICOAT dressing. At the 30 minute time point the dressing with INTRASITE Gel still displayed a three log reduction in bacteria, but displayed the same level of kill at 2 hours. A log reduction of 3 or greater is considerable with regard to antimicrobial efficacy. Assuming that 10,000,000 bacteria were present at the outset (equating to 10 7 ) a 3 log reduction would equate to a reduction to 10,000 CFU (Colony Forming Units). If the log reduction was greater than 4 this would equate to less than 1000 CFU remaining and a log reduction of greater than 5 would equates to less than 100 CFU present after the test period. After 2 hours, the log reduction was 4.3 for S.aureus which would equate to less than 1000 CFU present. With P. aeruginosa, the antimicrobial was faster acting. The log reduction of 5.3 would equate to less than 100 CFU after 30 minutes. Discussion No significant impact on zones of inhibition was detected with treating ACTICOAT with INTRASITE Gel. This study showed that the ACTICOAT continued to give a considerable reduction in bacteria at both time points. The results give confidence that the two dressings can be used in combination without comprising the antimicrobial efficacy of ACTICOAT.
8 In-Vitro assessments of the compatibilty of ACTICOAT and INTRASITE Gel dressings cont... Test 2: The rheological effect of INTRASITE Gel when used with ACTICOAT Method Eight samples of ACTICOAT dressing were coated with INTRASITE Gel. INTRASITE Gel was applied at 2mm/cm 2 (equivalent to 20g over a 10x10cm dressing). Samples were aged at 32 o C for up to seven days sealed in light / moisture impregnable foil pouches. After 0, 1, 2 and 7 days, duplicate samples were removed from storage. Samples coated with INTRASITE Gel were scraped and the gel rheology determined. The standard specification oscillation and flow tests were performed in attempts to determine whether the INTRASITE GEL was being adversely affected by anything that the ACTICOAT was excreting or absorbing. In addition, a creep test was performed, measuring the displacement that the sample made under a suitable low load. Also, a more complex oscillation test was used to try and determine the limit of elasticity when oscillated at zero frequency. All tests were performed on TA AR 500 Rheometer with temperature 25oC / Parallel plate with a 2mm (2000um) gap. Results The INTRASITE Gel that was removed from ACTICOAT dressings during the test did become discoloured as it absorbed silver, however this discolouration diminished over time taking on a brownish yellow colour after 7 days. the subjective texture and appearance of the INTRASITE Gel after removal from the acticoat dressings did not feel different from between the fingers of the operator. The rheological data showed that over the course of the test, the INTRASITE Gel did show a slight increase in viscosity and elasticity (see fig 1), but this was not evident subjectively. Figure 1 Figure 1 Elasticity of Intrasite gel after contact with Acticoat dressings for up to 7 days. Elasticity (G ) and Dynamic Viscosity (n 5Hz/50 Pa Discussion There is little noticeable rheological effect on the INTRASITE Gel from being in contact with ACTICOAT for a one day, two day, or seven day period. Over the 7 day period of this experiment, the INTRASITE Gel is subjectively the same to the touch, although rheological data shows it to be slightly thicker and stiffer. The results of this test suggest that ACTICOAT and INTRASITE Gel are compatible for use together.
9 In-Vitro assessments of the compatibilty of ACTICOAT and INTRASITE Gel dressings cont. Conclusions Clinicians do use ACTICOAT and ACTICOAT 7 in conjunction with INTRASITE Gel in the treatment of chronic wounds, and this is supported by both in-vitro and in-vivo data. The in-vitro tests suggest that although discolouration of the gel is observed, the bioactivity is not compromised. The case study results provide in-vivo evidence that when used together, ACTICOAT and ACTICOAT 7 with INTRASITE Gel can provide an effective treatment regime for chronic wounds that may be susceptible to infection.
10 Notes
11 Notes
12 Wound Management Smith& Nephew Medical Ltd 101 Hessle Road Hull HU3 2NB England TM SILCYRST is a trade mark of NUCRYST Pharmaceutical Corp.; used under licence Trademarks of Smith & Nephew
Partnering the burn community
* At smith&nephew we seek imaginative solutions that improve wound outcomes for patients and at the same time conserve resources for healthcare systems. Partnering the burn community Dedicated to the management
More informationAgenda (45 minutes) Some questions for you. Which wound dressing? Dressing categories/types. Summary
Dressing selection Agenda (45 minutes) Some questions for you. Which wound dressing? Dressing categories/types Summary Which wound dressing poster Ref: Which wound dressing? Practice Nursing, September
More informationSupporting healthcare professionals in taking control of the infection risk with ACTICOAT Flex TAKE CONTROL. of the infection risk in chronic wound
Supporting healthcare professionals in taking control of the infection risk with ACTICOAT Flex TAKE CONTROL of the infection risk in chronic wound Introduction The impact of infection on patients is well
More informationWhat did we find living under some silver dressings? * NEW in vitro Evidence. Not all silver dressings are created equal. *As demonstrated in vitro
NEW in vitro Evidence What did we find living under some silver dressings? * Not all silver dressings are created equal.. Micro-contouring, bacteria killing* 1,2 *As demonstrated in vitro Dressing technology
More informationLower Extremity Wound Evaluation and Treatment
Lower Extremity Wound Evaluation and Treatment Boni-Jo Silbernagel, DPM Describe effective lower extremity wound evaluation and treatment. Discuss changes in theories of treatment in wound care and implications
More informationMean percent reduction in ulcer area from baseline at six weeks 62 % SANTYL Ointment + supportive care* + sharp debridement 1 (P<0.
Evaluating two common adjuncts to sharp debridement in the treatment of diabetic foot ulcers Mean percent reduction in ulcer area from baseline at six weeks 62 % 40 % SANTYL Ointment + supportive care*
More informationTopical antimicrobials (antiseptics) Iodine, Silver, Honey
Topical antimicrobials (antiseptics) Iodine, Silver, Honey Iodine Honey Silver Enzymatic debridement Proteolytic enzyme, also called Proteinase Proteinase breaks the long chainlike molecules of proteins
More informationArglaes provides a seven-day, non-cytotoxic barrier against infection
Arglaes provides a seven-day, non-cytotoxic barrier against infection Arglaes Controlled-Release Silver Technology Reduce bioburden with Arglaes Silver Barrier Dressings Antimicrobial Arglaes began the
More informationGalen ( A.D) Advanced Wound Dressing
Galen (120-201A.D) Advanced Wound Dressing Wounds heal optimally in a moist environment นพ.เก งกาจ ว น ยโกศล Wound assessment Ideal wound dressing Type of wound Clinical appearance Wound location Measurement
More informationRN Cathy Hammond. Specialist Wound Management Service at Nurse Maude Christchurch
RN Cathy Hammond Specialist Wound Management Service at Nurse Maude Christchurch 14:00-14:55 WS #141: Wound Infection - What You Need to Know 15:05-16:00 WS #153: Wound Infection - What You Need to Know
More informationWe look forward to serving you.
ADVANCED CARE GEMCORE360 offers healthcare professionals a simple, clear and cost-effective wound care range while ensuring excellent clinical outcomes for their patients. 1 At GEMCO Medical, we strive
More informationApplication Guide for Full-Thickness Wounds
Application Guide for Full-Thickness Wounds PriMatrix Dermal Repair Scaffold PriMatrix Ag Antimicrobial Dermal Repair Scaffold Application Guide for Full Thickness Wounds PriMatrix is a unique dermal repair
More informationAn investigation of Cutimed Sorbact as an antimicrobial alternative in wound management
An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management G Kammerlander, E Locher, A Suess-Burghart, B von Hallern, P Wipplinger Abstract Background: Antimicrobial dressings
More informationDRESSING SELECTION. Rebecca Aburn MN NP Candidate
DRESSING SELECTION Rebecca Aburn MN NP Candidate Should be individually tailored in conjunction with the patient to meet their individual needs. WOUND MANAGEMENT: Comprehensive health assessment Wound
More informationAppropriate Dressing Selection For Treating Wounds
Appropriate Dressing Selection For Treating Wounds Criteria to Consider for an IDEAL DRESSING Exudate Management Be able to provide for moist wound healing by absorbing exudate or adding moisture Secure
More informationINTRODUCTION TO WOUND DRESSINGS
WOUND CARE INTRODUCTION TO WOUND DRESSINGS JEC 2017 Wound Care Successfully completed specialized skills training in Wound Management. WOUND CONDITIONS & SYMBOLS BY COLOURS Yellow Black Necrotic tissue
More informationHydroTherapy: A simple approach to Wound Management
Copyright Paul Hartmann Pty Ltd material may not be reproduced or used without written permission HydroTherapy: A simple approach to Wound Management HARTMANN Education Agenda Agenda Acute vs Chronic wounds:
More informationAdvazorb. Hydrophilic foam dressing range
Advazorb Hydrophilic foam dressing range Advazorb A comprehensive range of patient friendly, absorbent foam dressings Non-adhesive and atraumatic silicone adhesive options Designed to manage exudate whilst
More informationBIOSORB GELLING FIBRE DRESSING. Key facts: In vitro evidence
BIOSORB GELLING FIBRE DRESSING Key facts: In vitro evidence BIOSORB Gelling Fibre Dressing WHAT IS IT? BIOSORB Gelling Fibre Dressing is a soft, conformable non-woven dressing made from sodium carboxymethyl
More informationNovoSorb BTM. A unique synthetic biodegradable wound scaffold. Regenerating tissue. Changing lives.
NovoSorb BTM A unique synthetic biodegradable wound scaffold Regenerating tissue. Changing lives. Overview NovoSorb BTM is a unique synthetic biodegradable wound scaffold that delivers good cosmetic and
More informationCase study: A targeted approach to healing complex wounds using the geko device.
Case study: A targeted approach to healing complex wounds using the geko device. Authors: Mr Sameh Dimitri Consultant Vascular and Endovascular Surgeon MSc FRCS (Eng Edin) Nikki Pavey Physiotherapist at
More informationResources to Guide the Management of Suspected Infection in Chronic Wounds
Resources to Guide the Management of Suspected Infection in Chronic Wounds Health Improvement Scotland published their 13th Health Technology Assessment (HTA 13) in December 2015 entitled, Antimicrobial
More informationEvaluation of Antibacterial Effect of Odor Eliminating Compounds
Evaluation of Antibacterial Effect of Odor Eliminating Compounds Yuan Zeng, Bingyu Li, Anwar Kalalah, Sang-Jin Suh, and S.S. Ditchkoff Summary Antibiotic activity of ten commercially available odor eliminating
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationImpregnated tulle dressing containing silver promotes healing of wounds and treats the wound margins Atrauman Ag tested in clinical practice
Impregnated tulle dressing containing silver promotes healing of wounds and treats the wound margins Atrauman Ag tested in clinical practice Wound management Conclusion In an observational study of 86
More informationDRESSING SELECTION SIMPLIFIED
10 DRESSING SELECTION SIMPLIFIED It must be recognised that no one dressing provides the optimum environment for the healing of all wounds (Mahoney, 2015) DRESSING SELECTION SIMPLIFIED Selecting the correct
More informationMANAGEMENT OF DIABETIC WOUNDS : HEALTH CLINIC SETTING DR NORLIZAH PAIDI FAMILY MEDICINE SPECIALIST KLINIK KESIHATAN BANDAR MAS KOTA TINGGI JOHOR
MANAGEMENT OF DIABETIC WOUNDS : HEALTH CLINIC SETTING DR NORLIZAH PAIDI FAMILY MEDICINE SPECIALIST KLINIK KESIHATAN BANDAR MAS KOTA TINGGI JOHOR OUTLINE DEFINITION FACTORS CONTRIBUTING TO WOUND DEVELOPMENT
More informationMulti-Center Clinical Results with PluroGel PSSD in Chronic Wounds
Multi-Center Clinical Results with PluroGel PSSD in Chronic Wounds Presented at a Satellite Symposium during the European Wound Management Association (EWMA) 2012 24 May 2012 Vienna, Austria Multi-Center
More informationFundamentals Of Wound Management. Julie Hewish Senior Tissue Viability Nurse
Fundamentals Of Wound Management Julie Hewish Senior Tissue Viability Nurse Wound Management What are we trying to achieve? Maintaining a controlled set of local conditions that is able to sustain the
More informationAbilar Questions and Answers
Abilar Questions and Answers Question Answer Product Information What is Abilar Resin Salve? What are the main properties of Abilar? How is Resin different from colophony (rosin)? Abilar Resin Salve is
More informationMaking strides toward effective diabetic foot treatment. Foot and ankle solutions from smith&nephew
Making strides toward effective diabetic foot treatment Foot and ankle solutions from smith&nephew 11.3% of the US population over the age of 20 has diabetes. 1 (American Diabetes Association) 65,000 diabetics
More informationJohn Timmons, David Gray, Fiona Russell
Silflex soft silicone wound contact dressing It is hard to believe that it has taken so long for the message to get through, that dressings and dressing removal should not cause additional pain or trauma
More informationProntosan. Clean. Easy Wound Healing. Wound Cleansing
Prontosan Clean. Easy Wound Healing. Wound Cleansing CoE Infection Control Prontosan the unique combination of Betaine & Polihexanide reduces healing time removes and prevents biofilm prevents infections
More informationYour guide to wound debridement and assessment. Michelle Greenwood. Lorraine Grothier. Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust
Your guide to wound debridement and assessment Michelle Greenwood Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust Lorraine Grothier Clinical Nurse Specialist, Tissue Viability, Central Essex
More informationDiagnosing wound infection - a clinical challenge
Diagnosing wound infection - a clinical challenge Keith F Cutting Merimbula, 5 th November 2010 Wound infection microbial load immune system microbial load + + + immune system infection host response Diagnosing
More informationTissue Viability Service Wound Management Primary Care Formulary 2017
Tissue Viability Service Wound Management Primary Care Formulary 2017 WMPF/TVS: March 2017 Review date: March 2019 Product Group Current Product Sizes Price per Item Hydrogel 1st Activheal Hydrogel 2nd
More informationAssessment & Management of Wounds in primary practice.
Assessment & Management of Wounds in primary practice. Nutrition Successful wound management depends on appropriate nutritional support. Poor nutrition is recognised as one of the major causes of poor
More informationGP Practice Woundcare Formulary
Agreed jointly by Ipswich and East Suffolk and West Suffolk Clinical Commissioning Groups GP Practice Woundcare Formulary Version 28 October 2017 Formulary items should be prescribed wherever possible.
More informationWound Care in the Community. Lisa Sutherland MSc Tissue Viability Senior Lead Ipswich Hospital & Community NHS Trusts
Wound Care in the Community Lisa Sutherland MSc Tissue Viability Senior Lead Ipswich Hospital & Community NHS Trusts What are the key elements? What is the patient s goal or aim for the wound? What are
More informationChronic wounds need an ideal microenvironment. NEXODYN TM can support the physiological healing process.
Chronic wounds need an ideal microenvironment. can support the physiological healing process. Wound microenvironment of chronic wounds represents a major therapeutic challenge¹ The most relevant factors
More informationTHERAPIES. HAND IN HAND. Need safe and efficient infection prevention and management? 1 The Cutimed. Closing wounds. Together.
Closing wounds. Together. Need safe and efficient infection prevention and management? 1 The Cutimed Sorbact range. A responsible choice. THERAPIES. HAND IN HAND. www.bsnmedical.co.uk TOGETHER WE CAN MAKE
More informationThe Power of a Hydroconductive Wound Dressing with LevaFiber Technology
The Power of a Hydroconductive Wound Dressing with LevaFiber Technology The first step in healing a chronic wound is to detoxify it by removing slough, necrotic tissue, exudate and bacteria, while keeping
More informationTissue Viability Service Wound Management Primary Care Formulary 2017
Tissue Viability Service Wound Management Primary Care Formulary 2017 WMPF/TVS: March 2017 Review date: March 2019 Product Group Current Product Sizes Price per Item Hydrogel 1st Activheal Hydrogel 2nd
More informationAdvancing the science of wound bed preparation
Advancing the science of wound bed preparation How Drawtex wound dressing works LevaFiber Technology provides three different types of action. Mechanisms of Action Capillary Action Hydroconductive Action
More informationSAMPLE. HLTEN406A Undertake basic wound care. Learner resource. HLT07 Health Training Package. Version 2
HLT07 Health Training Package HLTEN406A Undertake basic wound care Learner resource Version 2 Training and Education Support Industry Skills Unit Meadowbank Acknowledgments The TAFE NSW Training and Education
More informationThe impact of introducing a new foam dressing in community practice
Efficiency in wound care: The impact of introducing a new foam dressing in community practice ABSTRACT An audit of resource use was undertaken in 35 patients treated by two ambulatory wound care providers
More informationPalliative Care. EPUAP/NPUAP Publish New Pressure Ulcer Guidelines for. Treatment. Improving Quality of Care Based on CMS Guidelines 39
Treatment EPUAP/NPUAP Publish New Pressure Ulcer Guidelines for Palliative Care Dealing with the end of a loved one s life is difficult enough, but when wound and skin care issues are involved, the decisions
More informationIntroducing Mepilex Transfer Ag It all adds up to undisturbed healing. Antimicrobial wound contact layer with Safetac technology
Introducing Mepilex Transfer Ag It all adds up to undisturbed healing Antimicrobial wound contact layer with Safetac technology Mepilex Transfer Ag Help the body heal The importance of less pain The body
More informationTIME CONCEPT AND LOCAL WOUND MANAGEMENT
TIME CONCEPT AND LOCAL WOUND MANAGEMENT B. BRAUN WOUND CARE INTRODUCTION: TIME is a global care framework used to implement appropriate care plans and promote wound healing Tissue Management Inflammation
More informationNanogen Aktiv. Naz Wahab MD, FAAFP, FAPWCA Nexderma
Nanogen Aktiv Naz Wahab MD, FAAFP, FAPWCA Nexderma Patient BM 75 y.o female with a history of Type 2 Diabetes, HTN, Hypercholesterolemia, Renal insufficiency, Chronic back Pain, who had undergone a L3-L4
More informationAnseong Factory : 70-17, Wonam-ro, Wongok-myeon, Anseong-si, Gyeonggi-do , REPUBLIC OF KOREA
Care for tomorrow The Solution for Management HQ & Factory : 7, Hyeongjero4Beon-gil, Namsa-myeon, Cheoin-gu, Yong-in-si, Gyeonggi-do 449-884, REPUBLIC OF KOREA TEL: +8-3-33-33 / FAX: +8-3-33-34 Anseong
More informationCase study: Young athlete suffering from PTS recovers from traumatic foot ulcer, following use of the geko TM device.
Case study: Young athlete suffering from PTS recovers from traumatic foot ulcer, following use of the geko TM device.... Subject 34-year-old male, ex professional rugby player. Wound Type Lower left leg
More informationEssity Internal. Taking the fear out of wound infection: conquering everyday issues
Taking the fear out of wound infection: conquering everyday issues Learning objectives 1. Identifying the cost which wound infection can have on both the patient and healthcare organisations 2. Understanding
More informationClinical observation study in 624 patients confirms good efficacy and tolerability
Treatment of infected and infection-prone wounds with Atrauman Ag Clinical observation study in 624 patients confirms good efficacy and tolerability Wound management Summary More than 600 patients with
More informationClinical observation study in 624 patients confirms good efficacy and tolerability
Studie_Atrauman_Ag_GB.qxd 09.01.2006 13:32 Uhr Seite 6 Treatment of infected and infection-prone wounds with Atrauman Ag SD (0105) 087 078/3 Clinical observation study in 624 patients confirms good efficacy
More informationAdvanced Wound Care. Cut Shape Innovate
Advanced Wound Care Cut Shape Innovate Vacutex incorporates a patented three layer construction of poly-cotton elements that promotes an accelerated capillary action on wound interfaces. Effectively lifting,
More informationThe Triangle of Wound Assessment
The Triangle of Wound Assessment A simple and holistic framework for wound management CPWSC_TOWA_Brochure_210x210_2018.indd 1 10/01/2018 15.13 ? We asked healthcare professionals around the world about
More informationBiological Consulting Services
Biological Consulting Services of North Florida/ Inc. May 13, 2009 Aphex BioCleanse Systems, Inc. Dear Sirs, We have completed antimicrobial efficacy study on the supplied Multi-Purpose Solution. The testing
More informationHow is 1st MTP joint fusion carried out? Patient Information: Big Toe Fusion Metatarsophalangeal (MTP)
Patient Information: Big Toe Fusion Metatarsophalangeal (MTP) How is 1st MTP joint fusion carried out? You will be asked to wash your feet thoroughly on the day of operation and keep them clean, as this
More informationFoam dressings have frequently
The practical use of foam dressings Efficient and cost-effective management of excessive exudate continues to challenge clinicians. Foam dressings are commonly used in the management of moderate to heavily
More informationHemostasis Inflammatory Phase Proliferative/rebuilding Phase Maturation Phase
The presenters are staff members of the CHI Health St. Elizabeth Burn and Wound Center. Many of the products discussed are used in our current practice but we have no conflict of interest to disclose.
More informationKnee arthroscopy. Physiotherapy Department. Patient information leaflet
Knee arthroscopy Physiotherapy Department Patient information leaflet What is a knee arthroscopy? A knee arthroscopy is a type of keyhole surgery performed through small cuts in the skin. An instrument
More informationVenous Leg Ulcers. Care for Patients in All Settings
Venous Leg Ulcers Care for Patients in All Settings Summary This quality standard focuses on care for people who have developed or are at risk of developing a venous leg ulcer. The scope of the standard
More informationPrecise excision. Preserve viable tissue and reduce time to closure (1,2)
Precise excision Preserve viable tissue and reduce time to closure (1,2) Precision to preserve Conventional surgical excision Non-viable tissue VERSAJET II excision More precise tissue removal Non-viable
More informationHuman Tissues Department, Biotechnology Research Center, Tripoli- Libya P.O.Box: 30313,
Human Tissues Department, Biotechnology Research Center, Tripoli- Libya P.O.Box: 30313, Abstract Amniotic membranes obtained from placentae of healthy mother donors screened seronegative to HIV, HBV, and
More informationSurgical Management of wounds, flaps, grafts, and scars
Disclosures Surgical Management of wounds, flaps, grafts, and scars I have no financial disclosures Cherrie Heinrich, MD, FACS Department of Plastic Surgery Regions Hospital Assistant Professor University
More informationAnterior Cervical Discectomy
Anterior Cervical Discectomy Issue 5: March 2016 Review date: February 2019 Following your recent MRI scan and consultation with your spinal surgeon, you have been diagnosed with having a cervical disc
More informationAcute and Chronic WOUND ASSESSMENT. Wound Assessment OBJECTIVES ITEMS TO CONSIDER
WOUND ASSESSMENT Acute and Chronic OBJECTIVES Discuss classification systems and testing methods for pressure ulcers, venous, arterial and diabetic wounds List at least five items to be assessed and documented
More informationA Pilot Study of Oxygen Therapy for Acute Leg Ulcers
A Pilot Study of Oxygen Therapy for Acute Leg Ulcers Background: The concept of increasing the oxygen concentration in healing wounds developed originally with hyperbaric oxygen therapy and from the fact
More informationThe Proven Multifunctional Dressing
The Proven Multifunctional Dressing belongs to an innovative class of multifunctional wound care dressings. dressings effectively cleanse, fill, absorb and moisten wounds throughout the healing continuum.
More informationPRODIGY Quick Reference Guide
PRODIGY Quick Venous leg ulcer infected How do I assess a venous leg ulcer? Chronic venous insufficiency and venous hypertension result from damage to the valves in the veins of the leg and inadequate
More informationA GUIDE TO THE TREATMENT OF PRESSURE ULCERS FROM GRADE 1 GRADE 4
A GUIDE TO THE TREATMENT OF PRESSURE ULCERS FROM GRADE 1 GRADE 4 Gill Wicks, Nurse Consultant, Tissue Viability for Wiltshire Primary Care Trust and Lecturer at University of West England Pressure ulcers
More informationFemoro-femoral bypass surgery. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.
Femoro-femoral bypass surgery Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England. Discovery has made every effort to ensure that we obtained the information
More informationPOLYHEAL MICRO - INSTRUCTIONS FOR USE
POLYHEAL MICRO - INSTRUCTIONS FOR USE PRODUCT DESCRIPTION PolyHeal Micro is a medical device indicated for the treatment of wounds. It is comprised of a suspension of polystyrene negatively charged microspheres
More informationWound Jeopardy: Name That Wound Session 142 Saturday, September 10 th 2011
Initial Wound Care Consult History Physical Examination Detailed examination of the wound Photographs Cultures Procedures TCOM ABI Debridement Management Decisions A Detailed History and Physical (wound)
More informationOpen Wound( 개방창상 ) 피부나점막의손상이있는경우 ex)abrasion, Burn,Laceration 등 Closed Wound( 폐쇄창상 ) 피부나점막의손상이없는내부조직의손상 ex)closed Fracture, Ligament tear 등
신체조직의연속성이파괴된상태 Open Wound( 개방창상 ) 피부나점막의손상이있는경우 ex)abrasion, Burn,Laceration 등 Closed Wound( 폐쇄창상 ) 피부나점막의손상이없는내부조직의손상 ex)closed Fracture, Ligament tear 등 Partial Thickness Skin Injury - dermis 의일부만손상을입은경우
More informationFemoral shaft fracture surgery (femoral nailing)
Femoral shaft fracture surgery (femoral nailing) Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England. Discovery has made every effort to ensure that
More informationWound Management. E. Foy White-Chu, MD, CWSP
Wound Management E. Foy White-Chu, MD, CWSP E. Foy White-Chu, MD, CWSP Assistant Professor, OHSU Wound Medical Director, VAPORHCS List the Four Principles of Wound Bed Preparation Determine safe debridement
More informationWound Dressing. Choosing the Right Dressing
Wound Dressing Choosing the Right Dressing Benefits of using the correct Drsg Helps create the optimal wound environment Increases healing rates Reduces pain Decreases infection rates Cost effective Care
More informationTopical antimicrobial agents in wound care. Professor Val Edwards-Jones Manchester Metropolitan University UK
Topical antimicrobial agents in wound care Professor Val Edwards-Jones Manchester Metropolitan University UK Antimicrobial agents Antibacterial agents Antifungal agents Antiviral agents Antiparasitic agents?others
More informationThe Risk. Background / Bias. Integrating Wound Care into a Limb Preservation Initiative 4/24/2009
Stimulating Wound Granulation: Advances in NPWT and other Measures (Wound Bed Preparation) Charles Andersen MD, FACS, FAPWCA Clinical Prof of Surgery UW, USUHS Chief Vascular/Endovascular/ Limb Preservation
More informationFemoro-popliteal bypass surgery. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.
Femoro-popliteal bypass surgery Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England. Discovery has made every effort to ensure that we obtained the
More information2008 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. CPT Copyright 2007 American Medical Association
Chronic Wound Care ASPS #1: Use of wound surface culture technique in patients with chronic skin ulcers (overuse measure) This measure may be used as an Accountability measure Clinical Performance Measure
More informationHow Wounds Heal: A Guide for the Wound-care Novice
C L I N I C A L P R A C T I C E How Wounds Heal: A Guide for the Wound-care Novice BY Christine Pearson Christine Pearson, RN, IIWCC, is a wound clinician for Vancouver Coastal Health and has worked in
More informationIndependent evaluation of BEMER physical vascular regulation therapy
of BEMER Liezl Naudé Advanced nurse specialist: wound management Advanced lower limb and wound management centre, Pretoria Heart 4 the Wounded 5-7 July Pretoria Introduction Lower limb wounds have always
More informationSimple, gentle and affordable. *smith&nephew V1STA Negative Pressure Wound Therapy
Simple, gentle and affordable *smith&nephew V1STA Negative Pressure Wound Therapy Smith & Nephew s extensive presence and portfolio means that for every wound, at every stage, there is an appropriate solution.
More informationSubcapital hip fracture surgery. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.
Subcapital hip fracture surgery Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England. Discovery has made every effort to ensure that we obtained the
More informationEmbrace the Call to Wound Prevention and Care
CONCLUSION Embrace the Call to Wound Prevention and Care A challenging career Be part of an interprofessional team Help patients, families, communities Commit to lifelong learning To cure occasionally,
More informationCASE REPORT Use of a Hydroconductive Dressing to Treat a Traumatic Avulsive Injury of the Face
CASE REPORT Use of a Hydroconductive Dressing to Treat a Traumatic Avulsive Injury of the Face Colin Jerome Perumal, BDS, a and Martin Robson, MD b a Department of Maxillofacial and Oral Surgery, Medical
More informationAn evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds Sylvie Hampton
Wounds UK An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds Sylvie Hampton Wounds UK, 2007, Vol 3, No An evaluation of the efficacy of Cutimed Sorbact in different
More informationWorkshop on Debridement
MEDICINSK TEKNIK I SÅRDIAGNOSTIK OCH SÅRBEHANDLING Monday, 20 th of april 2015 Stockholm Sweden Workshop on Debridement Sources for best practice Reference documents available in several languages : WHY
More informationI ve a drawer full of dressings i don t know how to use!
I ve a drawer full of dressings i don t know how to use! Introduction: Originating from battlefield medicine much of what we use today is an evolution of material science combined with our understanding
More informationToe and forefoot amputation. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.
Toe and forefoot amputation Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England. Discovery has made every effort to ensure that we obtained the information
More informationEvaluation of the Use of a Silver Collagen Amorphous Gel in the Healing of Post Surgical and Dehisced Lesions
Evaluation of the Use of a Silver Collagen Amorphous Gel in the Healing of Post Surgical and Dehisced Lesions Presented by: Kathryn Khandaker, RN, BSN, CWCN and Deanna Sue Kohl, RN, BSN, CWOCN, CFCN Introduction:
More informationWound and Ostomy Care: Basics and Troubleshooting
Wound and Ostomy Care: Basics and Troubleshooting Catherine Clarey-Sanford, PhD, RN, CWOCN Conflict of Interest No conflict of interest exists No commercial interest No financial benefits Specific wound
More informationACTIVHEAL PRODUCT RANGE MORE AFFORDABLE CLINICALLY EFFECTIVE WOUND CARE
NEW NEW UPGRADED NEW NEW NEW ACTIVHEAL PRODUCT RANGE MORE AFFORDABLE CLINICALLY EFFECTIVE WOUND CARE 2 ACTIVELY SUPPORTING THE NHS WE HAVE BEEN USING ACTIVHEAL PRODUCTS ON OUR FORMULARY NOW FOR 2 YEARS
More information1/5. Introduction. Primary endpoint Time to reach readiness for closure by surgical intervention or left for closure by secondary intention
1/5 Introduction Materials and methods Animal studies show that intermittent NPWT has potential to increase the rate of granulation tissue formation compared with adjustable intermittent (AI) NPWT 1 However,
More informationThe medicinal use of honey has been known since ancient
THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 13, Number 4, 2007, pp. 439 441 Mary Ann Liebert, Inc. DOI: 10.1089/acm.2007.6366 Bactericidal Activity of Different Types of Honey Against
More information